Okay, let's tackle this question. The question is about why salbutamol is preferred over adrenaline in asthma. Hmm, I need to recall the differences between these two drugs in the context of asthma management.

First, I remember that both are bronchodilators. Adrenaline is an alpha and beta-adrenergic agonist, while salbutamol is a selective beta-2 agonist. That's a key point. Beta-2 receptors are the ones in the bronchial smooth muscle, so targeting them specifically would be better for asthma without causing unwanted effects from alpha activity.

Wait, adrenaline's alpha effects could cause vasoconstriction. In asthma, we don't want to constrict blood vessels, especially in the airways. Also, beta-1 effects on the heart—adrenaline might increase heart rate and cardiac workload more than salbutamol. Since salbutamol is more selective, it's safer, especially in acute situations like an asthma attack where the patient's heart might be under stress.

Let me check the options. The correct answer should be something about selectivity for beta-2 receptors. The other options might include things like duration of action, availability, or other mechanisms. For example, maybe someone thinks adrenaline is better because it's a stronger bronchodilator, but the selectivity makes salbutamol safer and more effective for asthma specifically.

So the core concept here is beta-2 adrenergic agonists versus non-selective adrenergic agonists in asthma treatment. The correct answer is likely about beta-2 selectivity reducing systemic side effects. The wrong options might be about other factors like onset of action, but salbutamol has a faster onset than adrenaline in some cases? Or maybe they confuse adrenaline's role in anaphylaxis versus asthma.

I need to make sure the explanation covers why beta-2 selectivity is better, mentioning the receptors and the side effects from non-selective activation. Also, clarify that adrenaline isn't wrong entirely but has more side effects. The clinical pearl would be to remember the selectivity and its benefits.

**Core Concept**
This question examines the pharmacological basis for preferring beta-2 selective agonists over non-selective adrenergic agonists in asthma. Salbutamol (albuterol) is a **beta-2 adrenergic receptor agonist**, while adrenaline (epinephrine) activates **beta-1**, **beta-2**, and **alpha-adrenergic receptors**. Selectivity minimizes cardiac and vasoconstrictive side effects.

**Why the Correct Answer is Right**
Salbutamol selectively stimulates **beta-2 receptors** in bronchial smooth muscle, causing rapid bronchodilation. It avoids significant activation of **beta-1 receptors** (which increase heart rate and myocardial oxygen demand) and **alpha receptors** (which cause vasoconstriction). Adrenaline’s non-selectivity leads to systemic effects like tachycardia, arrhythmias, and peripheral vasoconstriction, making it less ideal for asthma. Beta-2 selectivity ensures targeted action with fewer adverse effects in acute asthma exacerbations.

**Why Each Wrong Option is Incorrect**
**Option A:** "Adrenaline has a faster onset of action" – Incorrect. Both drugs have similar onset times (~5–10 minutes via

✓ Correct Answer: B. β2 selectivity